• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2084次肝脏肿瘤热消融术后主要并发症的发生率及危险因素

The frequency and risk factors of major complications after thermal ablation of liver tumours in 2,084 ablation sessions.

作者信息

Huang Qiannan, Pang Mengya, Zeng Qingjing, He Xuqi, Zheng Rongqin, Ge Mian, Li Kai

机构信息

Department of Ultrasound, Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

出版信息

Front Surg. 2022 Sep 15;9:1010043. doi: 10.3389/fsurg.2022.1010043. eCollection 2022.

DOI:10.3389/fsurg.2022.1010043
PMID:36189384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9520062/
Abstract

BACKGROUND

To assess the frequency of major complications after thermal ablation of liver tumours and to determine risk factors for adverse events.

METHODS

A retrospective study was conducted between January 2015 and January 2021. A total of 2,084 thermal ablation sessions in 1,592 patients with primary and metastatic liver tumours were evaluated. The frequency of major complications was evaluated according to the Society of Interventional Radiology Standards, and putative predictors of adverse events were analysed using simple and multivariate logistic regression.

RESULTS

Thermal ablation-related mortality was 0.1% (2/2,084), with an overall major complication rate of 5.6% (117/2,084). The most frequent major complication was symptomatic pleural effusion (2.9%, 60/2,084). Multivariate logistic regression analysis revealed that a total maximum diameter of lesions >3 cm, microwave ablation (MWA) and MWA combined with radiofrequency ablation, intrahepatic cholangiocarcinoma and postoperative systemic inflammatory response syndrome were independent prognostic factors for major complications.

CONCLUSIONS

Thermal ablation of liver tumours is a safe procedure with an acceptable incidence of major complications. The risk factors identified in this study will help to stratify high-risk patients.

摘要

背景

评估肝肿瘤热消融术后主要并发症的发生率,并确定不良事件的危险因素。

方法

进行一项回顾性研究,时间跨度为2015年1月至2021年1月。共评估了1592例原发性和转移性肝肿瘤患者的2084次热消融治疗。根据介入放射学会标准评估主要并发症的发生率,并使用单因素和多因素逻辑回归分析不良事件的假定预测因素。

结果

热消融相关死亡率为0.1%(2/2084),总体主要并发症发生率为5.6%(117/2084)。最常见的主要并发症是有症状的胸腔积液(2.9%,60/2084)。多因素逻辑回归分析显示,病变总最大直径>3 cm、微波消融(MWA)以及MWA联合射频消融、肝内胆管癌和术后全身炎症反应综合征是主要并发症的独立预后因素。

结论

肝肿瘤热消融是一种安全的治疗方法,主要并发症发生率可接受。本研究确定的危险因素将有助于对高危患者进行分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5e/9520062/d949bd0086e4/fsurg-09-1010043-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5e/9520062/db50f5f36ba3/fsurg-09-1010043-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5e/9520062/d949bd0086e4/fsurg-09-1010043-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5e/9520062/db50f5f36ba3/fsurg-09-1010043-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d5e/9520062/d949bd0086e4/fsurg-09-1010043-g002.jpg

相似文献

1
The frequency and risk factors of major complications after thermal ablation of liver tumours in 2,084 ablation sessions.2084次肝脏肿瘤热消融术后主要并发症的发生率及危险因素
Front Surg. 2022 Sep 15;9:1010043. doi: 10.3389/fsurg.2022.1010043. eCollection 2022.
2
Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques.肝脏肿瘤热消融治疗的并发症:射频与微波消融技术的比较。
Clin Radiol. 2013 Jun;68(6):608-15. doi: 10.1016/j.crad.2012.12.008. Epub 2013 Feb 8.
3
Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.1235 次消融术中立体定向射频消融治疗肝肿瘤后主要并发症的频率和危险因素:15 年经验。
Eur Radiol. 2021 May;31(5):3042-3052. doi: 10.1007/s00330-020-07409-0. Epub 2020 Oct 30.
4
[Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: analysis of major complications in 693 patients].超声引导下经皮冷循环微波消融治疗原发性肝癌:693例患者主要并发症分析
Zhonghua Zhong Liu Za Zhi. 2012 Dec;34(12):945-9. doi: 10.3760/cma.j.issn.0253-3766.2012.12.014.
5
Liver abscess as a complication of microwave ablation for liver metastatic cholangiocarcinoma after bilioenteric anastomosis.胆肠吻合术后微波消融治疗肝转移胆管细胞癌后并发肝脓肿。
Int J Hyperthermia. 2011;27(5):503-9. doi: 10.3109/02656736.2011.555876.
6
Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma.经皮超声引导下热消融治疗肝内胆管细胞癌。
Br J Radiol. 2012 Aug;85(1016):1078-84. doi: 10.1259/bjr/24563774. Epub 2012 Feb 28.
7
Complications of microwave and radiofrequency lung ablation: personal experience and review of the literature.微波和射频肺消融术的并发症:个人经验和文献回顾。
Radiol Med. 2012 Mar;117(2):201-13. doi: 10.1007/s11547-011-0741-2. Epub 2011 Oct 21.
8
Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone.启用恒空间能量控制的微波消融治疗肝恶性肿瘤,以实现可预测的球形消融区域。
Int J Hyperthermia. 2018 Jun;34(4):492-500. doi: 10.1080/02656736.2017.1358408. Epub 2017 Aug 3.
9
Percutaneous microwave ablation for liver tumours adjacent to the marginal angle.经皮微波消融治疗靠近边缘角的肝肿瘤
Int J Hyperthermia. 2014 Aug;30(5):306-11. doi: 10.3109/02656736.2014.938702.
10
High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence.大肝癌的高功率微波消融:复发率及复发相关因素评估
Clin Radiol. 2015 Nov;70(11):1237-43. doi: 10.1016/j.crad.2015.06.092. Epub 2015 Jul 26.

引用本文的文献

1
Multi-Organ Denervation: The Past, Present and Future.多器官去神经支配:过去、现在与未来
J Clin Med. 2025 Apr 16;14(8):2746. doi: 10.3390/jcm14082746.
2
Postoperative SIRS after thermal ablation of HCC: Risk factors and short-term prognosis.肝癌热消融术后的全身炎症反应综合征:危险因素及短期预后
Heliyon. 2024 Jan 28;10(3):e25443. doi: 10.1016/j.heliyon.2024.e25443. eCollection 2024 Feb 15.

本文引用的文献

1
Systemic Inflammatory Response Syndrome After Surgery: Mechanisms and Protection.术后全身炎症反应综合征:机制与保护。
Anesth Analg. 2020 Dec;131(6):1693-1707. doi: 10.1213/ANE.0000000000005175.
2
Role of thermal ablation in the management of colorectal liver metastasis.热消融在结直肠癌肝转移治疗中的作用。
Hepatobiliary Surg Nutr. 2020 Feb;9(1):49-58. doi: 10.21037/hbsn.2019.06.08.
3
Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients.肝细胞癌射频消融术后并发症:一项涉及9411例日本患者的多中心研究
Liver Cancer. 2020 Jan;9(1):50-62. doi: 10.1159/000502744. Epub 2019 Oct 22.
4
Intrahepatic Cholangiocarcinoma and Thermal Ablation: Long-term Results of An Italian Retrospective Multicenter Study.肝内胆管癌与热消融:一项意大利回顾性多中心研究的长期结果
J Clin Transl Hepatol. 2019 Dec 28;7(4):287-292. doi: 10.14218/JCTH.2019.00036. Epub 2019 Nov 27.
5
Intra-Procedural CT/MR-Ultrasound Fusion Imaging Helps to Improve Outcomes of Thermal Ablation for Hepatocellular Carcinoma: Results in 502 Nodules.术中 CT/MR-超声融合成像有助于提高肝癌热消融治疗效果:502 个结节的结果。
Ultraschall Med. 2021 Apr;42(2):e9-e19. doi: 10.1055/a-1021-1616. Epub 2019 Oct 31.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南:肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
8
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
9
Thermal ablation of hepatocellular carcinoma in patients with abnormal coagulation function.异常凝血功能患者的肝细胞癌热消融治疗。
Int J Hyperthermia. 2018 Nov;34(7):1038-1043. doi: 10.1080/02656736.2017.1390787. Epub 2017 Oct 30.
10
AASLD guidelines for the treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌治疗指南。
Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086.